Hepatocellular Carcinoma in the Amsterdam Area: A Retrospective Analysis in 61 Patients

Reference

• Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. International Union against Cancer and Springer Verlag, Heidelberg 1966
   Google Scholar
• Bosch F X, Munoz N. Epidemiology of hepatocellular carcinoma. Liver cell carcinoma, P Bannasch, D Keppler, G Weber. Kluwer Academic Publishers, Dordrecht 1989; 3–14
   Google Scholar
• Doodsoorzaken Statistiek. Centraal Bureau voor de Statistiek, Voorburg 1990
   Google Scholar
• Schonland M M, Millward-Sadler G H, Wright D H, Wright R. Hepatic tumours. ch 38. Liver and biliary disease, R Wright, et al. W B Saunders, London 1979
   Google Scholar
• Sherlock S. Ch 28. Diseases of the liver and biliary tree.8th ed. Blackwell Scientific Publ, Edinburgh 1989
   Google Scholar
• Johnson P J, Krasner N, Portmann B, et al. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status and aetiology of underlying cirrhosis. Gut 1978; 19: 1022–1026
   PubMed Web of Science ®Google Scholar
• Beasly R P, Hwang Lu-Yu, Linc G C, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129–1133
   PubMed Web of Science ®Google Scholar
• Beasly RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations. Hepatology 1982; 2: S–26S; 21
   Web of Science ®Google Scholar
• Brechot C, Hadchouel M, Scotto J, et al. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver diseases. Proc Natl Acad Sci USA 1981; 78: 3906–3910
   PubMed Web of Science ®Google Scholar
• Brechot C, Desos F, Lugassy C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985; 312: 270–276
   PubMed Web of Science ®Google Scholar
• Horiike N, Mitchitaka K, Onji M, et al. HBV-DNA hybridization in hepatocellular carcinoma associated with alcohol in Japan. J Med Virol 1989; 28: 189–192
   PubMed Web of Science ®Google Scholar
• van Rensburg S J, Cook-Mozafarri P, van Schalwyk D J, et al. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985; 51: 713–726
   PubMed Web of Science ®Google Scholar
• Su D-L. Drinking water and liver cell cancer. An epidemiological approach to the etiology of this disease in China. Chin Med J 1979; 748–756
   PubMed Web of Science ®Google Scholar
• Okuda K. The Liver Cancer Study Group of Japan: primary liver cell cancers. Cancer 1980; 45: 2663–2669
   PubMed Web of Science ®Google Scholar
• Okuda K, Fujimoto I, Hanai A, Krano Y. Changing incidence of hepatocellular cancer in Japan. Cancer Res 1987; 47/18: 4967–4972
   Web of Science ®Google Scholar
• Kiyosawa K, Sodemaya T, Tanaka E, et al. Hepatitis C virus and hepatocellular carcinoma: additional evidence of causal link. Hepatology 1990; 12: 671–675
   PubMed Web of Science ®Google Scholar
• Zaman S N, Johnson R D, Johnson P J, et al. Risk factors of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; 2: 1357–1359
   PubMed Web of Science ®Google Scholar
• Bassendine MF. Aetiological factors in hepatocellular cancer. Clin Gastroenterol 1987; 1: 1–16
   Google Scholar
• Herman JJ. Cell proliferation and the aetiology of hepatocellular carcinoma. J. Hepatol 1988; 7: 305–309
   Web of Science ®Google Scholar
• Palmer J R, Rosenberg L, Kaufman DW et al. Oral contraceptive use and liver cancer. Am J Epidemiol 1989; 130: 878–882
   PubMed Web of Science ®Google Scholar
• Lee FI. Cirrhosis and hepatoma in alcoholics. Gut 1967; 7: 77–85
   Web of Science ®Google Scholar
• Berman M M, Libbey P, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favourable prognosis. Cancer 1980; 46: 1448–1455
   PubMed Web of Science ®Google Scholar
• Craig J R, Peters R L, Edmondson H A, Omata M. Fibrolamellar carcinoma of the liver: a tumour of adolescents and young adults with distinctive clinicopathologic features. Cancer 1980; 46: 372–379
   PubMed Web of Science ®Google Scholar
• Leuschner I, Harms D, Schmidt D. The association of hepatocellular carcinoma in the childhood with hepatitis B virus infection. Cancer 1988; 62: 2363–2369
   PubMed Web of Science ®Google Scholar
• Hsu H C, Wu M Z, Chang M H, et al. Childhood hepatocellular carcinoma develops extensively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol 1987; 5: 260–267
   PubMed Web of Science ®Google Scholar
• Lack E E, Neave C, Vawter GF. Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 1982; 6: 693–705
   PubMed Web of Science ®Google Scholar
• Lok A SF, Liang R HS, Chiu E KW, et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991; 100: 182–188
   PubMed Web of Science ®Google Scholar
• Knill-Jones R P, Buckle R M, Parsons V, et al. Hypercalcaemia increased parathyroid hormone activity in primary hepatoma. N Engl J Med 1970; 282: 704–708
   PubMed Web of Science ®Google Scholar
• Oldenburg W A, Heerden JA, van Sizemore G W, et al. Hypercalcaemia and primary hepatic tumours. Arch Surg 1982; 117: 1363–1366
   PubMedGoogle Scholar
• Ikeda T, Tozuka S, Hasamura Y, Takeuchi J. Prostaglandin E-producing hepatocellular carcinoma with hypercalcemia. Cancer 1988; 61: 1813–1814
   PubMed Web of Science ®Google Scholar
• Johnson P JJ, Portmann B, Williams R. Alpha-fetoprotein concentrations measured by radio-immunoassay in diagnosing and excluding hepatocellular carcinoma. Br Med J 1978; 2: 661–663
   PubMed Web of Science ®Google Scholar
• Liebman HA. and rest of names. Des-gamma-carboxy (abnormal) prothrombina as a serum-marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310: 1427–1431
   PubMed Web of Science ®Google Scholar
• Deyashiki Y, Nishioka Y, Takahashi K, et al. Evaluation of Des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma. Cancer 1989; 64: 2546–2551
   PubMed Web of Science ®Google Scholar
• Kamin P D, Bernardino M E, Green B. Ultrasonic manifestations of hepatocellular carcinoma. Radiology 1979; 131: 459–461
   PubMed Web of Science ®Google Scholar
• Tanaka S, Kitamura T, Imaoka S, et al. Hepatocellular carcinoma: sonographic and histologic correlation. AJR 1983; 140: 701–707
   PubMed Web of Science ®Google Scholar
• Taylor K JW, Ramos J, Morsse S S, et al. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology 1987; 164: 643–647
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Nomura F. Ultrasonic Doppler studies of hepatocellular carcinoma and comparison with other hepatic focal lesions. Gastroenterology 1989; 97: 1489–1497
   PubMed Web of Science ®Google Scholar
• Yoshida T, Matsue H, Okazaki N, Yoshino M. Ultrasonographic differentiation of hepatocellular carcinoma from metastatic liver cancer. J Clin Ultrasound 1987; 15: 431–437
   PubMed Web of Science ®Google Scholar
• Yoshimatsu S, Inoue Y, Ibukuro K, Suzuki S. Hypovascular hepatocellular carcinoma undetected at angiography and CT with iodized oil. Radiology 1989; 171: 343–347
   PubMed Web of Science ®Google Scholar
• Raby N, Karani J, Michell M, et al. Lipiodol enhanced CT scanning in assessment of hepatocellular carcinoma. Clin Radiol 1989; 40: 480–485
   PubMed Web of Science ®Google Scholar
• Jackson J E, Yeung E YC, McCarthy P, et al. Case report: lipiodol retention at the site of liver biopsy: a false positive result in the investigation of hepatocellular carcinoma. Clin Radiol 1989; 40: 538–540
   PubMed Web of Science ®Google Scholar
• Kanematsu T, Furuta T, Takenaka K, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98–102
   PubMed Web of Science ®Google Scholar
• Kasugai H, Kojima J, Tatsuta M, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989; 97: 965–971
   PubMed Web of Science ®Google Scholar
• Oka H, Kurioka N, Kin K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680–687
   PubMed Web of Science ®Google Scholar
• Tremolda F, Benevegnu L, Drago C, et al. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy. Hepatogastroenterology 1989; 36: 519–521
   PubMedGoogle Scholar
• Chen M-F, Hwang T-L, Jeng L-BB, et al. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989; 124: 1025–1028
   PubMedGoogle Scholar
• Takayasu K, Muramatsu Y, Moriyama N, et al. Clinical and radiologic assessments of the results of hepatectomy for small hepatocellular carcinoma and therapeutic arterial embolization for postoperative recurrence. Cancer 1989; 64: 1848–1452
   PubMed Web of Science ®Google Scholar
• Tang Z-Y. Small hepatocellular carcinoma. In: Tang Z-Y, Wu MC, Xia SS, eds. Primary liver cancer. China Academic Publishers/Springer Verlag, Beijing/Berlin 1989; 191–203
   Google Scholar
• Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270–284
   PubMed Web of Science ®Google Scholar
• Patt Y Z, Claghorn L, Charnsangavej C, et al. Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liver. Cancer 1988; 61: 1884–1888
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Takahashi M, Bussaka H, et al. Intraarterial infusion of 5-fluoro-2-deoxyuridine-C8 dissolved in a lymphographic agent in malignant tumors. A preliminary report. Cancer 1989; 64: 2437–2444
   PubMed Web of Science ®Google Scholar
• Livraghi T. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309–312
   PubMed Web of Science ®Google Scholar
• Okuda K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 cases. Cancer 1985; 56: 918–928
   PubMed Web of Science ®Google Scholar
• Paterlini P, Gerken G, Nakajina E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80–85
   PubMed Web of Science ®Google Scholar